Overview: Topical clobetasol is used to treat skin conditions that involve inflammation and itchiness, including psoriasis. Common side effects from topical clobetasol are skin reactions ...

Clobetasol propionate is available in the following forms, all of which are topical: cream, gel, foam, lotion, ointment, shampoo, spray, and liquid solution. The medication belongs to a drug class ...

To date, the Company has not received reports of adverse events related to this recall. Taro Pharmaceuticals has issued a voluntary recall of 1 lot of Clobetasol Propionate Ointment USP, 0.05% ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Clobetasol propionate ophthalmic suspension 0.05% ...

whereby Harrow has acquired the exclusive U.S. commercial rights for BYQLOVI™ (clobetasol propionate ophthalmic suspension) 0.05%. BYQLOVI was recently approved by the U.S. Food and Drug ...

Eyenovia acquired the U.S. commercial rights to clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals in August 2023. Formosa’s proprietary APNT™ technology ...

Both coprimary endpoints were statistically significantly better in Clobetasol Propionate Ophthalmic Suspension 0.05%-treated patients compared with vehicle-treated patients. The Food and Drug ...

Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Apotex for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic ...